Pfizer Limited (NSE:PFIZER)
5,329.50
+222.50 (4.36%)
Aug 14, 2025, 3:30 PM IST
Pfizer Revenue
Pfizer had revenue of 6.03B INR in the quarter ending June 30, 2025, with 7.14% growth. This brings the company's revenue in the last twelve months to 23.22B, up 4.35% year-over-year. In the fiscal year ending March 31, 2025, Pfizer had annual revenue of 22.81B with 4.02% growth.
Revenue (ttm)
23.22B
Revenue Growth
+4.35%
P/S Ratio
10.50
Revenue / Employee
14.53M
Employees
1,598
Market Cap
243.74B
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Mar 31, 2025 | 22.81B | 881.80M | 4.02% |
Mar 31, 2024 | 21.93B | -2.32B | -9.55% |
Mar 31, 2023 | 24.25B | -1.86B | -7.13% |
Mar 31, 2022 | 26.11B | 3.71B | 16.54% |
Mar 31, 2021 | 22.40B | 887.20M | 4.12% |
Mar 31, 2020 | Pro | Pro | Pro |
Mar 31, 2019 | Pro | Pro | Pro |
Mar 31, 2018 | Pro | Pro | Pro |
Mar 31, 2017 | Pro | Pro | Pro |
Mar 31, 2016 | Pro | Pro | Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Sun Pharmaceutical Industries | 537.77B |
Divi's Laboratories | 96.52B |
Cipla | 274.80B |
Apollo Hospitals Enterprise | 225.51B |
Mankind Pharma | 129.10B |
Zydus Lifesciences | 236.08B |
Fortis Healthcare | 80.94B |
Aurobindo Pharma | 320.25B |
Pfizer News
- 8 hours ago - Pfizer shares jump over 5% as Q1 net profit surges 27.2% YoY - Business Upturn
- 2 days ago - Pfizer shares jump over 2% after launch of next-gen 20-valent pneumococcal vaccine in India - Business Upturn